Clinical impact of weekly paclitaxel plus cetuximab is comparable to the EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma

JOURNAL ARTICLE published July 2021 in International Journal of Clinical Oncology

Research funded by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology of Japan (JP20K18331) | Health Labour Sciences Research Grant (20ck0106438h0003)

Authors: Risa Motai | Michi Sawabe | Shigenori Kadowaki | Eiichi Sasaki | Daisuke Nishikawa | Hidenori Suzuki | Shintaro Beppu | Hoshino Terada | Nobuhiro Hanai